NGMedical to showcase spine portfolio at Eurospine and NASS

NGMedical GmbH will exhibit at Eurospine in Gothenburg and NASS in San Antonio as it pushes its motion-preservation spine products into more international markets. The company says more than five new market launches are planned over the next five months, backed by 6.5 years of clinical experience with its cervical disc technology.

Why it matters: - NGMedical is using two major global spine conferences to expand surgeon, distributor and market access at the same time. - The company’s push comes as it adds new countries in 2026 and targets more than five international market launches in the next five months. - The strategy could widen adoption of its motion-preservation devices beyond its current footprint.

What happened: - NGMedical will present at Eurospine in Gothenburg and NASS in San Antonio. - The company will show its product portfolio, including MOVE®-C, described as the only articulating-viscoelastic cervical artificial disc. - Peter Weiland, CEO of NGMedical, said the company is excited to present at both events in 2026 and values in-person meetings with surgeons and distributing partners.

The details: - Visitors will be able to evaluate the full product portfolio at both congresses. - NGMedical is positioning the lineup around the next generation of cervical motion preservation. - The company cites more than 6.5 years of clinical experience as proof of product safety and function. - NGMedical says its 2026 international expansion includes several new countries. - The company’s broader portfolio includes MOVE®-P for lumbar motion preservation and state-of-the-art fusion products. - More information is available on the company’s website.

Between the lines: - The dual-conference presence signals a sales-and-partnership strategy, not just a product announcement. - The emphasis on clinical experience is aimed at strengthening credibility with surgeons and distributors. - The company is trying to balance motion-preservation technology with fusion offerings, which may help it compete across different spine-surgery preferences.

What’s next: - NGMedical plans to add several new countries in 2026. - The company expects more than five international market launches within the next five months. - Eurospine and NASS will be the main near-term venues for showing the portfolio and supporting international growth.

The bottom line: - NGMedical is turning two high-profile spine meetings into a platform for broader global expansion and faster commercial rollout of its motion-preservation devices.